
The depressed brain encourages rigid thought patterns that impact well-being. This can be viewed as a “landscape” with deep wells that make it difficult for patients to “move between” different thoughts and perspectives.
Image by Richard Daws, Kings College London

Psilocybin therapy “flattens” the brain’s landscape and “opens up” the rigidity of the depressed to allow new thoughts, insight, and perspectives to emerge.
Image by Richard Daws, Kings College London

Post-treatment, a flatter landscape makes it easier for patients to experience healthier flexibility and diversity in their thought patterns.
Image by Richard Daws, Kings College London
Study Suggests New Mechanism for How Psychedelics Affect the Brain
Psilocybin fosters greater connections between different regions of the brain in depressed people, freeing them up from long-held patterns of rumination and excessive self-focus, according to a new study by scientists at UC San Francisco and Imperial College London.
The discovery points toward a general mechanism through which psychedelics may be acting therapeutically on the brain to alleviate depression and possibly other psychiatric conditions that are marked by fixed patterns of thinking.
Scientists analyzed fMRI brain scans from nearly 60 people who had participated in two psilocybin trials. In the first one, all the participants had treatment-resistant depression and knew they were being given psilocybin. In the second one, the participants were depressed but not as severely, and they were not told whether they had been given psilocybin or a placebo that turned out to be escitalopram, an SSRI antidepressant. In addition to the drugs, all the participants received the same type of psychotherapy.
The scans, which were done before and after treatment, showed the psilocybin treatment reduced connections within brain areas that are tightly connected in depression, including the default mode, salience, and executive networks, and increased connections to other regions of the brain that had not been well integrated.
Participants were also less emotionally avoidant and their cognitive functioning got better. The improvement in their depressive symptoms correlated with changes to their brains, and these changes lasted until the study ended three weeks after the second psilocybin dose. No such changes were seen in the brains of those who received escitalopram, suggesting that psilocybin acts differently on the brain than SSRIs.
Psilocybin and other serotonergic psychedelics like ayahuasca affect 5-HT2A receptors, which are plentiful in brain networks that become overactive in depression. One hypothesis is that the drugs briefly disrupt these connections, giving them a chance to reform in new ways in the ensuing days and weeks.
“In previous studies we had seen a similar effect in the brain when people were scanned whilst on a psychedelic, but here we’re seeing it weeks after treatment for depression, which suggests a carry-over of the acute drug action,” said Robin Carhart-Harris, PhD, who directs the Neuroscape Psychedelics Division at UCSF and is the senior author of the study, which appears April 11, 2022, in Nature Medicine.
“We don’t yet know how long the changes in brain activity seen with psilocybin therapy last, and we need to do more research to understand this,” said Carhart-Harris, who is the Ralph Metzner Distinguished Professor of Neurology, Psychiatry, and Behavioral Sciences and a member of the UCSF Weill Institute for Neurosciences. “We do know that some people relapse, and it may be that after a while their brains revert to the rigid patterns of activity we see in depression.”
The authors caution that while these findings are encouraging, patients with depression should not attempt to self-medicate with psilocybin. The trials took place under controlled, clinical conditions, using a regulated dose formulated in a laboratory, and involved extensive psychological support before, during, and after dosing.
But the study points to a mechanism that, if it holds up, may explain both how psilocybin helps to alleviate depression and potentially other debilitating psychiatric conditions.
“For the first time we find that psilocybin works differently from conventional antidepressants – making the brain more flexible and fluid, and less entrenched in the negative thinking patterns associated with depression,” said David Nutt, DM, head of the Imperial Centre for Psychedelic Research. “This supports our initial predictions and confirms psilocybin could be a real alternative approach to depression treatments.”
Original Article: Psilocybin Rewires the Brain for People with Depression
More from: University of California San Francisco | Imperial College London
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Psilocybin
- Why psychedelics produce some of the most meaningful experiences in people’s lives
Scientists are beginning to ask why everything seems so profound on psychedelics, including ketamine, DMT, ayahuasca, MDMA, and more.
- Baby boomers, contemplating their mortality, are taking psychedelics again
Old age can be a time of introspection, spiritual exploration and search for meaning. A carefully-planned psychedelic experience can fulfill that.
- Cannabis and psilocybin: Wild disparity in what doctor can say in Iowa and Colorado
As a physician in the field of psychiatry in both Iowa and Colorado, where the drug laws regarding cannabis (marijuana) and psychedelics such as psilocybin are entirely different, my legal and medical ...
- Many users of Oregon’s new legal psilocybin clinics appear to come from out of state
Though data about clients at Oregon’s new legal psilocybin clinics is protected by privacy rules, it appears that many are coming from outside the state. Freelance journalist Grant Stringer talked to ...
- Psilocybin shows promise for treating eating disorders, but more controlled research is needed
As a doctoral student in the field of neuropsychiatry with a personal interest in EDs, I delved into the literature to assess the evidence for psilocybin-assisted therapy in ED treatment.
Go deeper with Google Headlines on:
Psilocybin
[google_news title=”” keyword=”psilocybin” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Psychedelics
- Why psychedelics produce some of the most meaningful experiences in people’s lives
Scientists are beginning to ask why everything seems so profound on psychedelics, including ketamine, DMT, ayahuasca, MDMA, and more.
- Baby boomers, contemplating their mortality, are taking psychedelics again
Old age can be a time of introspection, spiritual exploration and search for meaning. A carefully-planned psychedelic experience can fulfill that.
- The Evolutionary Origins of Psychedelics
Lately, though, some have also turned to psychedelics like psilocybin to change their perspectives. In fact, researchers are beginning to test if they could serve as new treatments for mental health ...
- Why Psychedelics Produce the Most Meaningful Experiences
In 1882, sitting at his desk with a pen and open notebook, Harvard philosopher William James inhaled a thick cloud of nitrous oxide — better known today as laughing gas, the stuff your dentist uses to ...
- Why psychedelics produce some of the most meaningful experiences in people’s lives
Despite the past two decades of research documenting the tight relationship between psychedelics and meaningful experiences, we still know surprisingly little about what’s actually going on in ...
Go deeper with Google Headlines on:
Psychedelics
[google_news title=”” keyword=”psychedelics ” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]